Sonnet BioTherapeutics Provides Fiscal Year 2023 Second Quarter and Year-to-Date Business and Earnings Update

Sonnet BioTherapeutics Holdings, Inc. announced today its financial results for the three months and six months ended March 31, 2023 and provided a business update.